Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-12.04%
↑ 75% vs avg
Percentile
P60
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-48.05%
Historical baseline
| Period | Value |
|---|---|
| 2024 | -12.04% |
| 2023 | -42.11% |
| 2022 | -52.34% |
| 2021 | -181.84% |
| 2020 | 0.00% |
| 2019 | 0.00% |